Skip to main content

journal publication Archives

Making order out of ordinal data

Jun. 12, 2012—A new statistical tool developed by Vanderbilt biostatisticians will help medical researchers make sense of a commonly encountered – but hard-to-analyze – type of data.

Read more


DNA: From modification to mutation

Jun. 8, 2012—Understanding how an environmental hazard damages DNA may shed light on processes of tumor formation.

Read more


Long live the therapeutic stem cells

May. 17, 2012—Enhancing stem cell survival is key to improving cell-based therapies for regenerative medicine, and a new drug could help.

Read more


New clue to ADHD

May. 15, 2012—A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD.

Read more


Perfect timing for sensory processing

May. 11, 2012—Identification of brain regions involved in processing sights and sounds may offer insights into disorders like autism and dyslexia.

Read more


Probing epilepsy’s molecular sparks

May. 10, 2012—Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies.

Read more


Early stomach troubles augur anxiety

May. 2, 2012—Children with stomach troubles grow up to be anxious adolescents and young adults, according to a recent study.

Read more


Better blood pressure-reducing drugs?

Apr. 30, 2012—A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome.

Read more


Dengue antibodies give vaccine leads

Apr. 27, 2012—New information may help speed development of a vaccine or treatment for dengue fever.

Read more


New drug mutes more melanomas

Apr. 26, 2012—An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies.

Read more


Neuronal clues to cholesterol-defect disorder

Apr. 20, 2012—Antioxidants may be a beneficial treatment for an inherited genetic disorder.

Read more


Pathways to delirium in the ICU

Apr. 17, 2012—Study suggests that the “kynurenine” biochemical pathway could be a target for reducing delirium and coma in critically ill patients.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more